Electrocardiographic Predictors of Adverse Cardiovascular Events in Suspected Poisoning

Journal of Medical Toxicology

Volumn 6, Issue 2, 2010, Pages 106-115

  Manini, Alex F ^a   Nelson, Lewis S ^b,c   Skolnick, Adam H ^d   Slater, William ^d   Hoffman, Robert S ^b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK CITY POISON CONTROL CENTER   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiovascular events; Electrocardiogram; Poisoning

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARDIOVASCULAR AGENT; HERBACEOUS AGENT; NEUROLEPTIC AGENT; NON PRESCRIPTION DRUG; OPIATE; PARACETAMOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ECG ABNORMALITY; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; INTOXICATION; MALE; PREDICTION; QRS COMPLEX; QT DISPERSION; QT INTERVAL; QT PROLONGATION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SHOCK; SINUS RHYTHM;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FEMALE; HEART ARREST; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; OVERDOSE; PHARMACEUTICAL PREPARATIONS; POISON CONTROL CENTERS; POISONING; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; ROC CURVE; SUICIDE, ATTEMPTED;

EID: 77956190932     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-010-0074-x     Document Type: Article

References (42)

1. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE (2008) 2007 Annual report of the American Association of Poison Centers' National Poison Data System (NPDS): 25th annual report. Clin Toxicol (Phila) 46: 927-1057.
2. McCaig LF, Burt CW (1999) Poisoning-related visits to emergency departments in the United States, 1993-1996. J Toxicol Clin Toxicol 37: 817-826.
3. Paulozzi L, Crosby A, Ryan G (2007) Increases in age-group-specific injury mortality-United States, 1999-2004. MMWR 56: 1281-1284.
4. ESC Committee, Subcommittees, and Task Forces of the American Heart Association (2005) American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 112(24 Suppl): 1-203.
5. American Academy of Clinical Toxicology (1993) Facility assessment guidelines for regional toxicology treatment centers. J Toxicol Clin Toxicol 31: 211-217.
6. American College of Emergency Physicians (1996) Poison information and treatment systems. Ann Emerg Med 28: 384.
7. Thygesen K, Alpert JS, White HD (2007) Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 50: 2173-2195.
8. Henry CR, Satran D, Lindgren B, Adkinson C, Nicholson CI, Henry TD (2006) Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. JAMA 295: 398-402.
9. Satran D, Henry CR, Adkinson C, Nicholson CI, Bracha Y, Henry TD (2005) Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J Am Coll Cardiol 45: 1513-1516.
10. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction), American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Academic Emergency Medicine (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction. Circulation 116: e148-e304.
11. Manini AF, Kabrhel C, Thomsen TW (2005) Acute myocardial infarction following over-the-counter use of pseudoephedrine. Ann Emerg Med 45: 213-216.
12. Schoffstall JM, Spivey WH, Gambone LM, Shaw RP, Sit SP (1991) Effects of calcium channel blocker overdose-induced toxicity in the conscious dog. Ann Emerg Med 20: 1104-1108.
13. Boehnert MT, Lovejoy FH Jr (1985) Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 313: 474-479.
14. Huikuri HV, Castellanos A, Myerburg RJ (2001) Sudden death due to cardiac arrhythmias. N Engl J Med 345: 1473-1482.
15. Roden D, Woosley R, Primm R (1986) Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J 111: 1088-1093.
16. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321: 406-412.
17. Manini AF, Raspberry D, Hoffman RS, Nelson LS (2007) QT prolongation and torsades de pointes following overdose of ziprasidone and amantadine. J Med Toxicol 3: 178-181.
18. Yamaura K, Kao B, Iimori E, Urakami H, Takahashi S (1997) Recurrent ventricular tachyarrhythmias associated with QT prolongation following hydrofluoric acid burns. J Toxicol Clin Toxicol 35: 311-313.
19. Manini AF, Nelson LS, Hoffman RS (2007) Characteristics of poison-related fatality and timing of cardiac arrest. Clin Toxicol (Phila) 45: 388, abstract.
20. Fingerhut LA, Cox CS (1998) Poisoning mortality, 1985-1995. Public Health Rep 113: 218-233.
21. Centers for Disease Control and Prevention (2004) Unintentional and undetermined poisoning deaths - 11 states 1990-2001. MMWR 53: 233-238.
22. Liebelt EL, Francis PD, Wolf AD (1995) ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med 26: 195-201.
23. Committee for Proprietary Medicinal Products (1997) The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. Committee for Proprietary Medicinal Products, London.
24. Kenigsberg DN, Khanal S, Kowalski M, Krishnan SC (2007) Prolongation of the QTc interval is seen uniformly during early transmural ischemia. J Am Coll Cardiol 49: 1299-1305.
25. Calder K, Tomongin C, Mallon WK, Genna T, Bretsky P, Henderson SO (2002) Manual measurement of QT dispersion in patients with acute myocardial infarction and nondiagnostic electrocardiograms. Acad Emerg Med 9: 851-854.
26. Malik M, Batchvarov VN (2000) Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 36: 1749-1766.
27. Viskin S (1999) Long QT syndromes and torsades de pointes. Lancet 354: 1625-1633.
28. 2+ on aconitine-induced arrhythmias. Jpn Heart J 37: 709-718.
29. Teschemacher AG, Seward EP, Hancox JC, Witchel HJ (1999) Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline. Br J Pharmacol 128: 479-485.
30. Volders PG, Sipido KR, Vos MA, Spätjens RL, Leunissen JD, Carmeliet E et al (1999) Downregulation of delayed rectifier K (+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 100: 2455-2461.
31. Yan GX, Wu Y, Liu T, Wang J, Marinchak RA, Kowey PR (2001) Phase 2 early afterdepolarizations as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall. Circulation 103: 2851-2856.
32. Nelson LS (2002) Toxicologic myocardial sensitization. J Toxicol Clin Toxicol 40: 867-880.
33. Day CP, McComb JM, Campbell RW (1992) QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 67: 39-41.
34. Surawicz B (1989) Electrophysiologic substrate of torsades de pointes: dispersion of repolarization or early afterdepolarizations. J Am Coll Cardiol 14: 172-184.
35. Niemann JT, Bessen HA, Rothstein RJ, Laks MM (1986) Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol 57: 1154-1159.
36. Institute of Medicine, Board on Health Care Services (2006) Hospital-based emergency care: at the breaking point. National Academies Press, Washington, DC.
37. Straus SMJM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J et al (2006) Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 47: 362-367.
38. Mangoni A, Kinirons M, Swift C, Jackson S (2003) Impact of age on QT interval and QT dispersion in healthy subjects. Age Ageing 32: 326-331.
39. Priori SG, Aliot E, Blømstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P et al (2001) Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 22: 1374-1450.
40. Darbar D, Luck J, Davidson N, Pringle T, Main G, McNeill G et al (1996) Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ 312: 874-878.
41. Sauer AJ, Moss AJ, McNitt S, Peterson DR, Zareba W, Robinson JL et al (2007) Long QT syndrome in adults. J Am Coll Cardiol 49: 329-337.
42. Linakis JG, Frederick KA (1993) Poisoning deaths not reported to the regional Poison Control Center. Ann Emerg Med 22: 1822-1828.